Lexpos News

/Lexpos News

3 products re-classified as special containers from June 2026

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Semaglutide 1.5mg tablets Rybelsus® 1.5mg tablets (Novo Nordisk Ltd) 30 tablet        [...]

The post 3 products re-classified as special containers from June 2026 appeared first on Community Pharmacy England.

By |May 29th, 2026|Lexpos News|Comments Off on 3 products re-classified as special containers from June 2026

CPE secures 10% funding rise, but pushes for reform

Announcement Summary Funding to increase by 10.3% (£340m) in 2026/27 to £3.636 billion Government commits to working jointly on programme of reform, which will be critically important to set the future strategy for the sector Margin write-off up to end of 2025/26, and funding uplift includes £200 million to be added to the annual margin [...]

The post CPE secures 10% funding rise, but pushes for reform appeared first on Community Pharmacy England.

By |May 28th, 2026|Lexpos News|Comments Off on CPE secures 10% funding rise, but pushes for reform

MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited)

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/25 Date issued: 28 May 2026 Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site. DMRC reference number: DMRC-39617807 Company name: Crescent Pharma [...]

The post MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.

By |May 28th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited)

May 2026 Price Concessions 4th Update

The Department of Health and Social Care (DHSC) has today (28/05/2026) confirmed the following list of price concessions for May 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post May 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

By |May 28th, 2026|Lexpos News|Comments Off on May 2026 Price Concessions 4th Update

Funding & Reimbursement Shorts: Dispensing FP10MDA forms

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video to explain the dispensing and endorsing requirements for Controlled Drugs (CDs) prescribed on blue paper FP10MDA instalment prescription forms. In this video, Sarah Welbourne (Dispensing and Supply Officer) and Alisha Khatri (Dispensing and Supply Pharmacist) [...]

The post Funding & Reimbursement Shorts: Dispensing FP10MDA forms appeared first on Community Pharmacy England.

By |May 27th, 2026|Lexpos News|Comments Off on Funding & Reimbursement Shorts: Dispensing FP10MDA forms